Cargando…

Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data

BACKGROUND: In Uzbekistan, routine serologic testing has not been available to differentiate etiologies of acute viral hepatitis (AVH). To determine the age groups most affected by hepatitis E virus (HEV) during documented AVH epidemics, trends in AVH-associated mortality rate (MR) per 100,000 over...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharapov, Makhmudkhan B, Favorov, Michael O, Yashina, Tatiana L, Brown, Matthew S, Onischenko, Gennady G, Margolis, Harold S, Chorba, Terence L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671511/
https://www.ncbi.nlm.nih.gov/pubmed/19320984
http://dx.doi.org/10.1186/1471-2334-9-35
_version_ 1782166387079249920
author Sharapov, Makhmudkhan B
Favorov, Michael O
Yashina, Tatiana L
Brown, Matthew S
Onischenko, Gennady G
Margolis, Harold S
Chorba, Terence L
author_facet Sharapov, Makhmudkhan B
Favorov, Michael O
Yashina, Tatiana L
Brown, Matthew S
Onischenko, Gennady G
Margolis, Harold S
Chorba, Terence L
author_sort Sharapov, Makhmudkhan B
collection PubMed
description BACKGROUND: In Uzbekistan, routine serologic testing has not been available to differentiate etiologies of acute viral hepatitis (AVH). To determine the age groups most affected by hepatitis E virus (HEV) during documented AVH epidemics, trends in AVH-associated mortality rate (MR) per 100,000 over a 15-year period and reported incidence of AVH over a 35-year period were examined. METHODS: Reported AVH incidence data from 1971 to 2005 and AVH-associated mortality data from 1981 to 1995 were examined. Serologic markers for infection with hepatitis viruses A, B, D, and E were determined from a sample of hospitalized patients with AVH from an epidemic period (1987) and from a sample of pregnant women with AVH from a non-epidemic period (1992). RESULTS: Two multi-year AVH outbreaks were identified: one during 1975–1976, and one during 1985–1987. During 1985–1987, AVH-associated MRs were 12.3–17.8 per 100,000 for the general population. Highest AVH-associated MRs occurred among children in the first 3 years of life (40–190 per 100,000) and among women aged 20–29 (15–21 per 100,000). During 1988–1995 when reported AVH morbidity was much lower in the general population, AVH-associated MRs were markedly lower among these same age groups. In 1988, AVH-associated MRs were higher in rural (21 per 100,000) than in urban (8 per 100,000) populations (RR 2.6; 95% CI 1.16–5.93; p < 0.05). Serologic evidence of acute HEV infection was found in 280 of 396 (71%) patients with AVH in 1987 and 12 of 99 (12%) pregnant patients with AVH in 1992. CONCLUSION: In the absence of the availability of confirmatory testing, inferences regarding probable hepatitis epidemic etiologies can sometimes be made using surveillance data, comparing AVH incidence with AVH-associated mortality with an eye to population-based viral hepatitis control measures. Data presented here implicate HEV as the probable etiology of high mortality observed in pregnant women and in children less than 3 years of age in Uzbekistan during 1985–1987. High mortality among pregnant women but not among children less than 3 years has been observed in previous descriptions of epidemic hepatitis E. The high mortality among younger children observed in an AVH outbreak associated with hepatitis E merits corroboration in future outbreaks.
format Text
id pubmed-2671511
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26715112009-04-22 Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data Sharapov, Makhmudkhan B Favorov, Michael O Yashina, Tatiana L Brown, Matthew S Onischenko, Gennady G Margolis, Harold S Chorba, Terence L BMC Infect Dis Research Article BACKGROUND: In Uzbekistan, routine serologic testing has not been available to differentiate etiologies of acute viral hepatitis (AVH). To determine the age groups most affected by hepatitis E virus (HEV) during documented AVH epidemics, trends in AVH-associated mortality rate (MR) per 100,000 over a 15-year period and reported incidence of AVH over a 35-year period were examined. METHODS: Reported AVH incidence data from 1971 to 2005 and AVH-associated mortality data from 1981 to 1995 were examined. Serologic markers for infection with hepatitis viruses A, B, D, and E were determined from a sample of hospitalized patients with AVH from an epidemic period (1987) and from a sample of pregnant women with AVH from a non-epidemic period (1992). RESULTS: Two multi-year AVH outbreaks were identified: one during 1975–1976, and one during 1985–1987. During 1985–1987, AVH-associated MRs were 12.3–17.8 per 100,000 for the general population. Highest AVH-associated MRs occurred among children in the first 3 years of life (40–190 per 100,000) and among women aged 20–29 (15–21 per 100,000). During 1988–1995 when reported AVH morbidity was much lower in the general population, AVH-associated MRs were markedly lower among these same age groups. In 1988, AVH-associated MRs were higher in rural (21 per 100,000) than in urban (8 per 100,000) populations (RR 2.6; 95% CI 1.16–5.93; p < 0.05). Serologic evidence of acute HEV infection was found in 280 of 396 (71%) patients with AVH in 1987 and 12 of 99 (12%) pregnant patients with AVH in 1992. CONCLUSION: In the absence of the availability of confirmatory testing, inferences regarding probable hepatitis epidemic etiologies can sometimes be made using surveillance data, comparing AVH incidence with AVH-associated mortality with an eye to population-based viral hepatitis control measures. Data presented here implicate HEV as the probable etiology of high mortality observed in pregnant women and in children less than 3 years of age in Uzbekistan during 1985–1987. High mortality among pregnant women but not among children less than 3 years has been observed in previous descriptions of epidemic hepatitis E. The high mortality among younger children observed in an AVH outbreak associated with hepatitis E merits corroboration in future outbreaks. BioMed Central 2009-03-25 /pmc/articles/PMC2671511/ /pubmed/19320984 http://dx.doi.org/10.1186/1471-2334-9-35 Text en Copyright ©2009 Sharapov et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sharapov, Makhmudkhan B
Favorov, Michael O
Yashina, Tatiana L
Brown, Matthew S
Onischenko, Gennady G
Margolis, Harold S
Chorba, Terence L
Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data
title Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data
title_full Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data
title_fullStr Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data
title_full_unstemmed Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data
title_short Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data
title_sort acute viral hepatitis morbidity and mortality associated with hepatitis e virus infection: uzbekistan surveillance data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671511/
https://www.ncbi.nlm.nih.gov/pubmed/19320984
http://dx.doi.org/10.1186/1471-2334-9-35
work_keys_str_mv AT sharapovmakhmudkhanb acuteviralhepatitismorbidityandmortalityassociatedwithhepatitisevirusinfectionuzbekistansurveillancedata
AT favorovmichaelo acuteviralhepatitismorbidityandmortalityassociatedwithhepatitisevirusinfectionuzbekistansurveillancedata
AT yashinatatianal acuteviralhepatitismorbidityandmortalityassociatedwithhepatitisevirusinfectionuzbekistansurveillancedata
AT brownmatthews acuteviralhepatitismorbidityandmortalityassociatedwithhepatitisevirusinfectionuzbekistansurveillancedata
AT onischenkogennadyg acuteviralhepatitismorbidityandmortalityassociatedwithhepatitisevirusinfectionuzbekistansurveillancedata
AT margolisharolds acuteviralhepatitismorbidityandmortalityassociatedwithhepatitisevirusinfectionuzbekistansurveillancedata
AT chorbaterencel acuteviralhepatitismorbidityandmortalityassociatedwithhepatitisevirusinfectionuzbekistansurveillancedata